They speculated that because of the lack of strong adhesion between polypoidal lesions and RPE layers, polyp regression after intravitreal anti-VEGF injections might not result in sufficient contractile force to allow RPE tear formation, and that the risk of RPE tears in eyes with PCV might be relatively lower than that for eyes with tAMD or RAP. The gene discussed is VEGFA; the disease is polyp.